Relapse Management Group Psychoeducation Program (NCT07327944) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Relapse Management Group Psychoeducation Program
60 participantsStarted 2026-02-01
Plain-language summary
This study was planned to be conducted between February and March 2026, with a total of 60 patients diagnosed with schizophrenia who met the inclusion criteria and were followed at the community mental health center in the Psychiatry Building of Ankara Etlik City Hospital. 30 patients were in the experimental group and 30 were in the control group.
Who can participate
Age range
18 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria
* Age 18 and over
* Able to speak and understand Turkish
* Written consent obtained
* Being a patient diagnosed with schizophrenia who is being monitored at the relevant institution during the study period
* Being in remission Exclusion Criteria
* Those who have previously received or are currently receiving psychoeducation on relapse management
* Those who do not attend community mental health center follow-ups regularly
* Those with mental retardation that may prevent participation in psychoeducation
* Those in the relapse phase of the disease
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Early Warning Signs of Relapse Questionnaire
Timeframe: Change from before implementation, after the practice is completed, 4 weeks after the practice is finished.
2
Functional Recovery Scale for Patients with Schizophrenia
Timeframe: Change from before implementation, after the practice is completed, 4 weeks after the practice is finished.